DE69203194T2 - Thiazolidine-2,4-dione für die Behandlung der Hypertonie. - Google Patents

Thiazolidine-2,4-dione für die Behandlung der Hypertonie.

Info

Publication number
DE69203194T2
DE69203194T2 DE69203194T DE69203194T DE69203194T2 DE 69203194 T2 DE69203194 T2 DE 69203194T2 DE 69203194 T DE69203194 T DE 69203194T DE 69203194 T DE69203194 T DE 69203194T DE 69203194 T2 DE69203194 T2 DE 69203194T2
Authority
DE
Germany
Prior art keywords
hypertension
formula
compounds
compound
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69203194T
Other languages
German (de)
English (en)
Other versions
DE69203194D1 (de
Inventor
Eric Robert Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69203194D1 publication Critical patent/DE69203194D1/de
Publication of DE69203194T2 publication Critical patent/DE69203194T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Removal Of Specific Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69203194T 1991-09-25 1992-09-14 Thiazolidine-2,4-dione für die Behandlung der Hypertonie. Expired - Fee Related DE69203194T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/765,643 US5175179A (en) 1991-09-25 1991-09-25 Method for treating hypertension

Publications (2)

Publication Number Publication Date
DE69203194D1 DE69203194D1 (de) 1995-08-03
DE69203194T2 true DE69203194T2 (de) 1995-11-02

Family

ID=25074097

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69203194T Expired - Fee Related DE69203194T2 (de) 1991-09-25 1992-09-14 Thiazolidine-2,4-dione für die Behandlung der Hypertonie.

Country Status (17)

Country Link
US (1) US5175179A (enExample)
EP (1) EP0534655B1 (enExample)
JP (1) JPH05194220A (enExample)
KR (1) KR950013756B1 (enExample)
AT (1) ATE124259T1 (enExample)
AU (1) AU644545B2 (enExample)
CA (1) CA2078901A1 (enExample)
DE (1) DE69203194T2 (enExample)
DK (1) DK0534655T3 (enExample)
ES (1) ES2073871T3 (enExample)
HU (1) HUT65276A (enExample)
IL (1) IL103202A0 (enExample)
MX (1) MX9205408A (enExample)
MY (1) MY129918A (enExample)
NZ (1) NZ244474A (enExample)
TW (1) TW209167B (enExample)
ZA (1) ZA927307B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
CA2577084A1 (en) * 2004-08-25 2006-03-02 Olivier Bezencon Bicyclononene derivatives as renin inhibitors
AU2006253805A1 (en) * 2005-05-27 2006-12-07 Actelion Pharmaceuticals Ltd. Novel piperidine carboxylic acid amide derivatives
NZ571595A (en) * 2006-03-08 2010-06-25 Actelion Pharmaceuticals Ltd New amines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
US5036079A (en) * 1989-12-07 1991-07-30 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
JP2826379B2 (ja) * 1990-01-22 1998-11-18 三共株式会社 チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤
ATE93138T1 (de) * 1990-02-09 1993-09-15 Upjohn Co Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.

Also Published As

Publication number Publication date
ES2073871T3 (es) 1995-08-16
HU9203052D0 (en) 1992-12-28
MX9205408A (es) 1993-03-01
DK0534655T3 (da) 1995-08-28
KR930005621A (ko) 1993-04-20
EP0534655A1 (en) 1993-03-31
MY129918A (en) 2007-05-31
HUT65276A (en) 1994-05-02
US5175179A (en) 1992-12-29
KR950013756B1 (ko) 1995-11-15
DE69203194D1 (de) 1995-08-03
AU2532692A (en) 1993-04-22
CA2078901A1 (en) 1993-03-26
JPH05194220A (ja) 1993-08-03
TW209167B (enExample) 1993-07-11
IL103202A0 (en) 1993-02-21
ATE124259T1 (de) 1995-07-15
AU644545B2 (en) 1993-12-09
EP0534655B1 (en) 1995-06-28
ZA927307B (en) 1994-03-24
NZ244474A (en) 1994-01-26

Similar Documents

Publication Publication Date Title
DE69214755T2 (de) Thiazolidin-2,4-Dionderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE69015587T2 (de) Hypoglykämische Oxazolidindion-Derivate.
DE2821966A1 (de) Spiro-hydantoinderivate und ihre verwendung
DE2731868C2 (enExample)
DE2933441A1 (de) Neue spiro-oxazolidindione und solche verbindungen enthaltende arzneimittel
DE2901477A1 (de) Thienohydantoinderivate und diese enthaltende arzneimittel
DE69625877T2 (de) Verwendung von 5-HT1A Rezeptor-Liganden zur Behandlung des Glaukoms
EP0010156B1 (de) 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
EP0166183B1 (de) Verwendung von Hydroxyindolderivaten zur Herstellung eines Arzneimittels zur Senkung des Blutdrucks
DE69005861T2 (de) Benzoxepin-Derivate.
DE19617864A1 (de) Neue chirale Phenyldihydrofuranone
DE3875324T2 (de) Dl-5-((2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl)thiazolidin-2,4-dion als antiatherosklerosemittel.
DE69023045T2 (de) Carboxamidderivate.
EP0301428A2 (de) Benzyldiaminopyrimidin-Derivate und deren Verwendung als Arzneimittel
DE1940566B2 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und diese enthaltende Arzneimittel
DE3889043T2 (de) N-(substituiertes Alkyliden)-1,2,3,4-tetrahydro-9-acridinamine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
EP0313935B1 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2822751A1 (de) Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
US5175179A (en) Method for treating hypertension
DE69129126T2 (de) Neue pharmazeutische formulierungen von 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol
EP0370499A2 (de) Verwendung von Benzomorphanen zur Zytoprotektion
EP0442141B1 (de) Pharmazeutische Zubereitung
CH658653A5 (de) Verfahren zur herstellung von pyrimidintrionderivaten.
WO1993024130A1 (de) (-)-metrifonat enthaltendes arzneimittel
EP0591486A1 (de) Immunaktivierende und damit antivirale wirking von 4- 3-(subst.-amino)-2-hydroxypropoxy]-1,2,5-thiadiazolverbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee